Categories AlphaGraphs, Health Care

PFE Earnings: All you need to know about Pfizer’s Q4 2021 earnings results

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today.

Revenues doubled year-over-year to $23.8 billion. Excluding contributions from Comirnaty and Paxlovid, revenues dropped 2% operationally, driven mainly by the impact of fewer selling days compared to the prior-year quarter.

On a reported basis, net income jumped to $3.3 billion, or $0.59 per share, from $847 million, or $0.15 per share, last year. Adjusted net income more than doubled to $6.2 billion, or $1.08 per share, versus last year.

For full-year 2022, revenues are expected to range between $98-102 billion while adjusted EPS is estimated to range between $6.35-6.55.

Prior performance

Pfizer reports Q3 2021 earnings results

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

MU Earnings: Micron’s Q4 profit declines but beats estimates

Micron Technology Inc. (NASDAQ: MU) Thursday said its fourth-quarter profit declined from last year, hurt by a sharp fall in revenues. Earnings, however, beat the market’s projection. On an adjusted

What are Philip Morris’ (PM) anticipations for the near term?

Shares of Philip Morris International Inc. (NYSE: PM) were down 1% on Thursday. The stock has dropped over 9% year-to-date. Although the tobacco industry has felt the pinch of inflation,

Key highlights from CarMax (KMX) Q2 2023 earnings results

CarMax, Inc. (NYSE:KMX) reported second quarter 2023 earnings results today. Net revenues rose 2% year-over-year to $8.1 billion. Net earnings were $125.9 million, or $0.79 per share, compared to $285.2 million,

Add Comment
Viewing Highlight